Results: Flow acceleration occurred in-stent but proximal to the cusps and again at the level of the cusps in all pts. EOA and DVI calculated using P-S values was significantly lower than when using I-SPC values. See table.
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Background: A postprocedural increase of the serum troponin I concentration (TnI) reflects myocardial injury and occurs frequently during transcatheter aortic valve implantation (TAVI). Periprocedural coronary microembolization is a potential cause of such injury. We therefore evaluated each step of the transfemoral TAVI procedure for coronary embolization using intracoronary Doppler (ICD) in the left anterior descending (LAD) artery. Methods: 15 high-risk patients with severe, symptomatic aortic valve stenosis who underwent transfemoral TAVI using the balloon-expandable Edwards bioprosthesis were included. ICD examinations were recorded and evaluated off-line for high-intensity transient signals (HITS). Perioperative concentrations of TnI were serially measured within the first 72 h after TAVI, and a cardiac MRI with late gadoliniumenhancement (LGE) was performed within 7 days. Results: HITS were detected in all patients, mostly during the initial crossing of the native valve and positioning of the prosthesis with subsequent implantation. TnI peaked at 24 h after TAVI (3.17 ng/ml), and LGE was observed in only one single case. There was no correlation between amount of HITS and TnI area under the curve in the first 72 h after TAVI.
Conclusions: Procedural HITS were detected by ICD in all patients undergoing transfemoral TAVI. The highest amount of HITS was observed during initial valve passage and positioning of the prosthesis with subsequent implantation. However, no association was found between the number of HITS and myocardial injury, as reflected by increased serum TnI concentrations or LGE on cardiac MRI.
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Transapical Hamburg University, Hamburg, Germany Background: The adverse impact of left ventricular dysfunction on survival after transcatheter aortic valve implantation (TAVI) has been documented. We report our experience with transapical TAVI in patients with reduced left ventricular function (LVEF) comparing first (balloon-expandable) and second (self-expanding) generation TAVI devices. Methods: From 3/2008 through 12/2012, a total of 75 patients presenting with preprocedural LVEF 45% underwent transapical TAVI, implanting either balloonexpandable prostheses (Edwards Sapien/Sapien XT) in 48 patients (BE; mean age 78.2AE7.9 years, 71% male) or self-expanding prostheses (JenaValve, n¼12; Symetis Accurate, n¼9; Medtronic Engager, n¼6) in 27 patients (SE; mean age 79.5AE6.7 years, 63% male), respectively. Calculated logistic EuroSCORE II and STS mortality scores were 12.6AE7.4% (BE) vs. 10.8AE5.4% (SE) (p¼ns) and 9.2AE6.6% (BE) vs. 9.2AE7.3% (SE) (p¼ns). Clinical and functional data were analysed according to the Valve Academic Research Consortium (VARC) endpoints. Results: Cumulative survival rates at 30 days and at one year were 87.5% (BE) vs. 96.3% (SE) (p¼ns) and 52.0% (BE) versus 60.5% (SE) (p¼ns), respectively. VARC device success and VARC combined 30-day safety endpoints were achieved in 87.5% (BE) vs. 85.2% (SE) (p¼ns) and 31.3% (BE) vs. 18.5% (SE) (p¼ns), respectively. Post-procedural aortic regurgitation >grade 1 did not differ between groups (8.4% (BE) vs. 11.1% (SE), p¼ns). However, aortic regurgitation !grade 1 was observed in 50.0% (BE) vs. 37.0% (SE) (p¼0.016). New onset of pacemaker indication was present in 10.4% (BE) vs. 7.4% (SE) (p¼ns). Mean ICU stay was 2.5AE2.6 days (BE) vs. 2.0AE1.8 days (SE) (p¼ns), whilst post-procedural hospital stay was 10.0AE3.8 days (BE) vs. 10.6AE6.6 days (SE) (p¼ns). Conclusions: Comparable survival rates and VARC endpoints were achieved in patients with reduced LVEF undergoing transapical TAVI either with balloon-expandable or with self-expanding prostheses. Further studies are required to evaluate the impact of a lower incidence of mild aortic regurgitation following implantation of selfexpanding valve types when compared to balloon-expandable prosthetic valves. 
